BSE filing, BSE: 544738. Summary written from the filing by ALFA Finder's alert engine.
Speciality Medicines Ltd: key numbers
- Share price
- ₹140.00
- Market cap
- ₹123.0 Cr
- Revenue (annual)
- ₹75.29 Cr
- Net profit (annual)
- ₹13.03 Cr
- P/E (TTM)
- 9.4×Sector 45.9×
- Promoter holding
- 43.43%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Speciality Medicines Ltd
All →Speciality Medicines Other Announcement
Speciality Medicines Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.
Speciality Medicines Annual General Meeting
Speciality Medicines Limited conducted its 5th Annual General Meeting on September 28, 2026. Shareholders considered the adoption of FY26 audited financial statements and the re-appointment of Director Sumit Goyani.
Speciality Medicines Annual General Meeting
Speciality Medicines Limited scheduled its 5th Annual General Meeting for September 28, 2026. The board also approved the draft Directors' Report for FY 2025-26.
Speciality Medicines Regulatory Approval
Speciality Medicines Limited received regulatory approval in Ethiopia for two additional pharmaceutical formulations, Olanzapine and Diazepam tablets. The company now has 12 registered products in Ethiopia.
Speciality Medicines Business Update
Speciality Medicines Limited received regulatory approval for two new products, Olanzapine and Diazepam tablets, in the Ethiopian market, strengthening its international export portfolio.
Speciality Medicines Other Announcement
Speciality Medicines Limited has appointed Capital Bridge Advisory Service Private Limited as its Investor and Public Relations agency to enhance its investor relations and communication efforts.
Other annual report announcements
All →Bhavik Enterprises Annual Report
Bhavik Enterprises rectifies an error in Notes 3.3 and 3.4 of its FY2025-26 audited financial statements. Promoter holdings were overstated by 10,00,000 shares that were sold in the IPO offer for sale.
Dalmia Bharat Sugar and Industries Annual Report
Dalmia Bharat Sugar released its Integrated Annual Report for FY2025-26. It covers the Tanzania entry, the demerger and the Baghauli integration.
Milestone Furniture Annual Report
Milestone Furniture published its 12th Annual Report for FY2025-26 with AGM notice for 21 November 2026. Agenda covers accounts, auditor appointment, capital increase and director appointments.
CMX Holdings Annual Report
Riwind Green Energy (formerly CMX Holdings) submitted its 35th Annual Report for FY 2025-26, acknowledging a delay in filing. The AGM was held on 30 September 2026.
Aesthetik Engineers Annual Report
Aesthetik Engineers filed its Integrated Annual Report for FY2025-26 with the 18th AGM notice. The AGM will be held on November 28, 2026 via video conferencing.
Evexia Lifecare Annual Report
Evexia Lifecare filed its FY 2025-26 Annual Report ahead of its 35th AGM on 30 September 2026. It contains financial and governance disclosures, with no new transaction.